Europe — EMA
Nitredon (Nitrazepam)
GNH USA supplies Nitredon (Nitrazepam), a benzodiazepine for insomnia, anxiety and seizure control, to hospitals and pharmacies worldwide. Request a quote.
Request sourcing
What is Nitrazepam?
Nitrazepam, the active ingredient in Nitredon, is a benzodiazepine presented as an oral tablet for oral use. It treats insomnia, anxiety disorders, and certain seizure types in adults.
GNH USA supplies Nitredon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Nitrazepam used for?
Nitrazepam, a benzodiazepine that enhances GABAergic inhibition, is indicated for several central nervous system conditions.
Insomnia: helps patients fall asleep and maintain sleep throughout the night. Anxiety disorders: reduces excessive worry and tension. Epileptic seizures: provides adjunctive control of certain seizure types.
What are the side effects of Nitrazepam?
Nitrazepam may cause a range of adverse reactions, from mild to severe.
Common Side Effects: - Drowsiness - Dizziness - Fatigue - Impaired coordination
Serious or Rare Side Effects: - Respiratory depression - Severe allergic reaction (anaphylaxis) - Withdrawal seizures
What precautions apply to Nitrazepam?
When prescribing Nitrazepam, clinicians should consider several safety measures.
Assess renal and hepatic function: adjust use in patients with severe impairment. Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal. Monitor for dependence: limit duration of therapy and assess risk regularly. Use caution in elderly: increased sensitivity to sedation and falls. Avoid use with other CNS depressants: risk of additive sedation. Store at room temperature: keep in the original container, protect from moisture and light.
What does Nitrazepam interact with?
Nitrazepam can interact with other medicines, altering its safety or effectiveness.
Major Interactions (Avoid): - Concurrent use with other benzodiazepines: risk of profound sedation. - Co‑administration with opioids: heightened respiratory depression. - Combination with alcohol: increased central nervous system depression.
Moderate Interactions (Monitor Closely): - Interaction with antiepileptic drugs (e.g., carbamazepine): may reduce efficacy. - Use with CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma levels.



